Prostate cancerMACA CANCER INFORMATION GUIDE

Understanding prostate cancer.

What prostate cancer is, the signs to look out for, the choices around testing, how it is diagnosed and staged, and the treatments your care team may discuss with you.

What is prostate cancer?

Prostate cancer begins when cells in the prostate gland grow out of control and form a tumour. Most prostate cancers grow slowly and may never cause harm, but some grow quickly and can spread to the lymph nodes, the bones and other parts of the body.

What the prostate is

The prostate is a small gland in men, about the size of a walnut. It sits just below the bladder and in front of the rectum (the back passage). It wraps around the urethra, the tube that carries urine from the bladder and out through the penis. The prostate makes some of the fluid that forms semen.

How common is prostate cancer?

Prostate cancer is the second most common cancer in men worldwide. In 2022, about 1.47 million men were diagnosed with prostate cancer and about 397,000 died from it. The number of new cases each year is expected to roughly double, to 2.9 million by 2040.

Prostate cancer in Nigeria and Africa

In Nigeria, prostate cancer is the most common cancer in men. In 2022 there were about 18,000 new cases, more than a third of all cancers diagnosed in Nigerian men, and about 11,400 deaths.

Men of African ancestry are more likely to develop prostate cancer than other men, and they tend to get it at a younger age. In Nigeria and across much of Africa, many men are diagnosed only when the cancer is already advanced and harder to treat. Knowing the signs and talking to a health worker early can change this.

Signs and symptoms

Early prostate cancer usually causes no symptoms. Symptoms often appear only when the cancer is large enough to press on the urethra, or has spread. Signs to look out for include:

  • Needing to pass urine more often, especially at night
  • Difficulty starting to pass urine, or straining
  • A weak or interrupted flow of urine
  • A feeling that the bladder has not emptied fully
  • Blood in the urine or semen
  • Problems getting or keeping an erection

Cancer that has spread can cause other symptoms, such as:

  • Pain in the back, hips or pelvis that does not go away
  • Tiredness and shortness of breath, which can be caused by a low red blood cell count (anaemia)
  • Weight loss without trying

Urinary problems are much more often caused by a non-cancerous enlarged prostate, called benign prostatic hyperplasia (BPH), or by an infection. But they should always be checked.

Risk factors

The causes of prostate cancer are not fully understood. Some things make it more likely, but many men with these risk factors never develop it. The main risk factors are:

  • Age: prostate cancer is rare in men under 40, and the chance of having it rises quickly after 50. About 6 in 10 prostate cancers are found in men older than 65.
  • African ancestry: Black men, including men in Africa and men of African heritage elsewhere, are more likely to develop prostate cancer, and tend to develop it younger.
  • Family history: having a father or brother with prostate cancer more than doubles a man’s risk.
  • Inherited gene changes: changes in the BRCA2 gene, and to a lesser extent BRCA1, increase the risk. These genes are also linked to breast and ovarian cancer, so a family history of those cancers can matter too. Lynch syndrome, an inherited condition, also increases the risk.

Testing and early detection

Prostate cancer that is found early, while it is still inside the prostate, is much easier to treat successfully. Two simple tests are used to check the prostate. Neither can show for certain whether you have cancer, but they help decide whether you need further tests.

The PSA blood test

PSA (prostate-specific antigen) is a protein made by the prostate. The PSA test measures how much of it is in your blood. A raised level can be a sign of prostate cancer, but it is also often raised by an enlarged prostate (BPH) or an infection or inflammation of the prostate (prostatitis).

There is no single “normal” PSA level. Doctors often use a level above 4 ng/mL as a reason for more tests, and they may adjust this for your age. Only about 1 in 4 men who have a biopsy because of a raised PSA are found to have cancer.

Some things can raise your PSA for a short time. For 48 hours before the test, avoid ejaculating, vigorous exercise and cycling. If you have a urine infection, the test is usually delayed for some weeks until it has cleared.

The digital rectal examination

In a digital rectal examination (DRE), a doctor gently puts a gloved, lubricated finger into your back passage to feel the prostate through the wall of the rectum. They check its size and feel for lumps or hard areas.

Many men feel embarrassed or anxious about this examination, and that is understandable. It is a routine medical check that doctors do often. It takes a minute or two and may be uncomfortable, but it should not be painful. You can ask for a chaperone to be present,. Please do not let worry about this test stop you from seeing a doctor.

Deciding whether to be tested

Testing men who have no symptoms is called screening. Experts do not all agree on PSA screening, because it has both benefits and harms:

  • Possible benefits: testing can find cancer early, before symptoms, when it is easier to treat. Regular PSA screening leads to a small reduction in deaths from prostate cancer.
  • Possible harms: a raised PSA can cause worry and lead to a biopsy that finds no cancer. Testing can also find slow-growing cancers that would never have caused harm, and treating them can cause side effects such as leaking urine or erection problems.

Because of this, the decision to have a PSA test is a personal one, best made after talking it through with your doctor. In the United States, men aged 55 to 69 are advised to make this choice with their doctor. Some organisations suggest starting the conversation earlier, at 40 or 45, for men at higher risk, including Black men and men with a family history of prostate cancer.

Types of prostate cancer

Almost all prostate cancers are adenocarcinomas. These start in the gland cells that make the fluid added to semen. Rarer types include small cell carcinoma and other neuroendocrine tumours, transitional cell carcinoma and sarcomas. These rare types often behave differently and are treated differently.

How fast it grows

Most prostate cancers grow slowly, and some men live for many years without the cancer causing problems. Others grow quickly and need treatment soon. Working out which kind you have is one of the most important parts of diagnosis.

Changes that are not cancer

A biopsy sometimes shows prostatic intraepithelial neoplasia (PIN), where the cells look abnormal but are not cancer. High-grade PIN can raise the risk of cancer developing later, so your doctor may suggest closer follow-up. Most often it does not turn into cancer.

Diagnosis

If your PSA is raised, your prostate feels abnormal or you have symptoms, your doctor will ask about your health and family history and may refer you to a urologist, a specialist in the urinary system and prostate. You may have the following tests.

MRI scan

An MRI scan uses magnets and radio waves to make detailed pictures of the prostate. It can show areas that may be cancer, help decide whether a biopsy is needed and guide the doctor to the right place if it is. An MRI on its own cannot confirm cancer.

Biopsy

A biopsy is the only sure way to diagnose prostate cancer. Small samples of tissue are taken with a thin needle and examined under a microscope by a pathologist.

  • Transrectal biopsy: the needle passes through the wall of the rectum, guided by an ultrasound probe. A local anaesthetic is usually given to numb the area.
  • Transperineal biopsy: the needle passes through the skin between the scrotum and the anus, usually under a local or general anaesthetic.

A biopsy can sometimes miss cancer, so it may need to be repeated.

Checking for spread

If cancer is found, you may have scans to check whether it has spread, especially if it looks likely to grow quickly. These can include a bone scan, a CT scan or a PSMA PET scan, a newer scan that is very good at finding prostate cancer cells in the body.

Stages and outlook

Gleason score and Grade Groups

The pathologist looks at the patterns of cancer cells in the biopsy and gives each of the two most common patterns a grade from 3 to 5. A grade of 3 looks most like normal tissue, and 5 looks most abnormal. The two grades are added together to give the Gleason score, which is usually between 6 and 10. The higher the score, the faster the cancer is likely to grow and spread.

The Gleason score is now also given as a Grade Group from 1 to 5, which is easier to understand:

  • Grade Group 1: Gleason score 6 or less. Slow-growing.
  • Grade Group 2: Gleason score 3 + 4 = 7. Mostly slow-growing cells, with some faster-growing ones.
  • Grade Group 3: Gleason score 4 + 3 = 7. Mostly faster-growing cells.
  • Grade Group 4: Gleason score 8.
  • Grade Group 5: Gleason score 9 or 10. The most likely to grow and spread quickly.

Stages

The stage combines the size and spread of the tumour, spread to lymph nodes and to other parts of the body (TNM), the PSA level and the Grade Group.

  • Stage I: the cancer is found only in the prostate, the PSA is below 10 and it is Grade Group 1.
  • Stage II: the cancer is still only in the prostate, with a PSA below 20 and Grade Group 1 to 4.
  • Stage III: the PSA is 20 or higher, or the cancer has grown outside the prostate into nearby tissue such as the seminal vesicles (glands that help make semen), or it is Grade Group 5.
  • Stage IV: the cancer has spread to nearby lymph nodes, or to other parts of the body, most often the bones (metastatic prostate cancer).

Your doctor may also describe your cancer as low, intermediate or high risk. This helps guide the choice of treatment.

Outlook

Prostate cancer found while it is still in or near the prostate has an excellent outlook. In the United States, more than 99% of men diagnosed at this point are alive five years later. When it has spread to distant parts of the body, about 38% are alive after five years, although treatment can often control it and relieve symptoms for a long time.

In Nigeria, many men are diagnosed when the cancer is already advanced, and more die from it. Finding prostate cancer earlier is the most important way to improve these results.

Treatment

Treatment depends on the stage and Grade Group of the cancer, your PSA, your age and general health, and what matters most to you. A team that may include urologists, oncologists, radiologists, pathologists and nurses plans it with you. Some treatments have long-term effects on passing urine and on erections, so take time to talk through the options before you decide.

Active surveillance

For low-risk cancer that is growing slowly, immediate treatment may not be needed. Active surveillance means checking the cancer closely with regular PSA tests, examinations, MRI scans and sometimes repeat biopsies. Treatment aimed at a cure is offered if the cancer shows signs of growing. This avoids or delays the side effects of treatment for men who may never need it.

Watchful waiting

Watchful waiting is a gentler approach, often for older men or men with other serious health problems. It does not aim to cure the cancer. Instead, treatment is given to control symptoms if and when they appear.

Surgery

A radical prostatectomy removes the whole prostate and the seminal vesicles. It can be done through a cut in the abdomen, by keyhole (laparoscopic) surgery or with robot-assisted surgery. It is used for cancer that has not spread beyond the prostate.

Radiotherapy

  • External beam radiotherapy: high-energy rays are aimed at the prostate from a machine outside the body, usually over several weeks. It is often combined with hormone therapy.
  • Brachytherapy: small radioactive sources are placed inside the prostate to treat it from within.

Hormone therapy

Prostate cancer usually needs male hormones (androgens), such as testosterone, to grow. Hormone therapy, also called androgen deprivation therapy, lowers these hormones or blocks their effect. It can be given as injections or tablets, or by an operation to remove the testicles (orchidectomy). It is used for advanced cancer and alongside radiotherapy. It can control the cancer for a long time, but it does not usually cure it on its own.

Chemotherapy

Chemotherapy uses medicines, such as docetaxel, to kill cancer cells throughout the body. It is used for cancer that has spread, often together with hormone therapy.

Newer treatments

  • Newer hormone medicines: such as abiraterone and enzalutamide, which block the effect of androgens more strongly.
  • Targeted therapy: PARP inhibitors, such as olaparib, for some advanced cancers with BRCA or similar gene changes.
  • Radioactive medicines: such as radium-223, which targets cancer that has spread to the bones, and PSMA-targeted treatments, which carry radiation directly to prostate cancer cells.
  • Bone treatments: medicines such as bisphosphonates or denosumab help protect the bones from damage caused by cancer or by hormone therapy.

Some of these newer treatments are not yet widely available in Nigeria or may be costly. Ask your care team which options are available to you.

Clinical trials

Clinical trials are research studies that test whether a new treatment, a new combination of treatments or a new way of giving an existing treatment works better than current care. Many of today’s standard treatments were first offered through clinical trials.

What taking part involves

  • Every trial has eligibility criteria, such as the type and stage of cancer, previous treatment and general health.
  • Trials must be approved by a research ethics committee and, for medicines, by the national regulator. In Nigeria this includes NAFDAC and a recognised health research ethics committee.
  • You will be given written information and asked for your informed consent before you join. You can ask questions at any time.
  • Taking part is voluntary. You can leave a trial at any point and still receive standard care.

Finding a trial

Your treating team is the best place to start, because they know your diagnosis and which trials could suit you. Trial registries list studies that are recruiting:

  • Pan African Clinical Trials Registry (PACTR): trials taking place in African countries.
  • WHO International Clinical Trials Registry Platform: one search across registries worldwide.
  • ClinicalTrials.gov: a large international registry run by the US National Library of Medicine.

Living with and after treatment

Bladder control

Leaking urine (incontinence) is common after surgery and can also happen after radiotherapy. For most men it improves over the following weeks and months. Pelvic floor exercises, which strengthen the muscles that control the flow of urine, can help. Ask your care team to show you how to do them.

Erections and sex life

Surgery, radiotherapy and hormone therapy can all cause problems getting or keeping an erection (erectile dysfunction). Hormone therapy can also lower your interest in sex. After surgery, you will no longer produce semen when you climax. These changes can be hard to talk about, but treatments such as tablets, injections and devices can help, and your care team will have helped many men with the same concerns. Include your partner in these conversations if you can.

Effects of hormone therapy

Hormone therapy can cause hot flushes, tiredness, weight gain, loss of muscle and weaker bones. Staying active, eating well and having your bone health checked can help.

Follow-up

After treatment you will have regular PSA tests and check-ups. A rising PSA can be an early sign that the cancer has come back, often long before any symptoms. Report any new pain, urinary problems or other changes between appointments.

Emotional health

A prostate cancer diagnosis can bring fear, worry and changes in how you see yourself as a man, a partner or a provider. Many men find it hard to talk about, and some keep it hidden from family and friends. Talking with your partner, people you trust, your care team or other men who have been through prostate cancer can help. Feeling low or anxious is common, and support is available.

Questions to ask your care team

  • What are the benefits and risks of a PSA test for me?
  • What is my PSA level, my Gleason score and Grade Group, and my stage?
  • Is my cancer low, intermediate or high risk?
  • Is active surveillance an option for me?
  • What are my treatment options, and what is the aim of each one?
  • How might treatment affect my bladder control and my erections, and what help is available?
  • Which treatments are available here, and what will they cost?
  • Should my brothers or sons be tested, or should I have a genetic test?
  • Is there a clinical trial that could be right for me?

LET’S KEEP THE CONVERSATION GOING

Understanding grows
when we come together.

Connect with MACA